FDA-Drug2014-10-08Class II
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
AbbVie Inc
Hazard
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Sold states
US: Nationwide
Affected count
18,021 Bottles
Manufactured in
1 N Waukegan Rd, N/A, North Chicago, IL, United States
Products
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1611-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief